查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1831791

低分子CDMO市場，規模，佔有率，趨勢，產業分析報告:各醫藥品類型，各產品，各用途，各地區-2025年～2034年的市場預測

Small Molecule CDMO Market Size, Share, Trend, Industry Analysis Report By Drug Type (Innovators, Generics), By Product, By Application, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2034年，小分子CDMO市場規模將達到1,336.3億美元。該報告深入分析了當前的市場動態，並分析了未來的市場成長。

小分子CDMO市場涵蓋專注於小分子化合物的合約開發和生產服務，為製藥和生物技術公司從早期開發到商業化生產的整個過程提供支援。該市場由日益增長的合約生產需求所驅動，旨在降低成本、加快進度，並獲得製劑、製程開發和法規遵循的專業知識。腫瘤學、罕見疾病和中樞神經系統治療的發展增加了計畫的複雜性，促使人們更加依賴CDMO來獲得客製化解決方案和靈活的能力。專利到期正在擴大仿製藥的研發管線，為建立具有成本效益的生產合作夥伴關係創造了機會。產業趨勢包括採用連續生產、綠色化學實踐和先進的分析能力，以提高效率並滿足嚴格的品質標準。藥物開發商和CDMO之間的策略聯盟日益普遍，從而實現風險共擔並加速創新。

對藥物生命週期內可擴展解決方案的需求日益增長，加上製程優化和自動化方面的進步，為供應商創造了巨大的機會，使其能夠透過技術深度和監管專業知識實現差異化。對上市速度的日益重視，尤其是對於小眾和罕見疾病藥物而言，進一步加強了能夠提供敏捷合規生產的專業CDMO的作用。競爭格局有利於那些投資於技術整合、擴展服務組合併建立穩固的長期合作夥伴關係以滿足不斷變化的治療和生產需求的參與者。

小分子CDMO市場報告重點

按產品類型劃分，由於越來越多的複雜合成工藝外包給專業的CDMO，活性藥物成分細分市場在2024年佔了市場主導地位。

按藥物類型劃分，由於新型小分子療法的外包量較大，創新藥物領域在 2024 年佔了最大的收入佔有率。

由於擁有先進的製藥生產基礎設施、完善的監管框架以及大型藥物開發公司的高外包需求，北美在 2024 年佔了小分子 CDMO 市場的主導地位。

由於製藥生產能力的擴大、對先進生產設備的投資增加以及對具有成本效益的外包解決方案的需求不斷增長，預計亞太市場將在 2025 年至 2034 年間實現最高的複合年增長率。

小分子 CDMO 市場的全球參與者包括 Aurigene Pharmaceutical Services Ltd.；Bellen Chemistry；Cambrex Corporation；Catalent, Inc.；CordenPharma International；Eurofins Scientific；Lonza；Recipharm AB；Siegfried Holding AG；和賽默飛世爾 目錄公司

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球低分子CDMO市場洞察

  • 市場概述
  • 低分子CDMO市場動態
    • 促進因素和機會
      • 仿製藥生產規模擴大
      • 新興治療領域的研發活動不斷增加
    • 限制因素與挑戰
      • 嚴格的監管要求和品質合規標準增加了營運複雜性
  • PESTEL分析
  • 小分子 CDMO 市場趨勢
  • 價值鏈分析

第5章 全球低分子CDMO市場:各產品

  • 主要調查結果
  • 簡介
  • 醫藥品有效成分(API)
  • 完成醫藥品

第6章 全球低分子CDMO市場:各醫藥品類型

  • 主要調查結果
  • 簡介
  • 創新者
  • 學名藥
  • 手冊

第7章 全球低分子CDMO市場:各用途

  • 主要調查結果
  • 簡介
  • 腫瘤學
  • 心血管疾病
  • 中樞神經系統(CNS)的疾病
  • 自體免疫/發炎
  • 其他

第8章 全球低分子CDMO市場:各地區

  • 主要調查結果
  • 簡介
    • 低分子CDMO市場分析:地區，2020～2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各醫藥品類型，2020～2034年
    • 北美:各用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各醫藥品類型，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各醫藥品類型，2020～2034年
    • 亞太地區:各用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各醫藥品類型，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各產品，2020-2034年
    • 南美:各醫藥品類型，2020～2034年
    • 南美:各用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Aurigene Pharmaceutical Services Ltd.
  • Bellen Chemistry
  • Cambrex Corporation
  • Catalent, Inc.
  • CordenPharma International
  • Eurofins Scientific
  • Lonza
  • Recipharm AB
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
Product Code: PM6332

The small molecule CDMO market size is expected to reach USD 133.63 billion by 2034, according to a new study by Polaris Market Research. The report "Small Molecule CDMO Market Size, Share, Trend, Industry Analysis Report By Drug Type (Innovators, Generics), By Product, By Application, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The small molecule CDMO market encompasses contract development and manufacturing services focused on low molecular weight drug compounds, supporting pharmaceutical and biotechnology companies from early-stage development through commercial production. The market is driven by increasing demand for outsourced manufacturing to reduce costs, accelerate timelines, and access specialized expertise in formulation, process development, and regulatory compliance. Growth in oncology, rare diseases, and central nervous system therapies is increasing project complexity, prompting greater reliance on CDMOs for tailored solutions and flexible capacity. Patent expirations are expanding the generic drug pipeline, generating opportunities for cost-effective production partnerships. Industry trends include the adoption of continuous manufacturing, green chemistry practices, and advanced analytical capabilities to enhance efficiency and meet stringent quality standards. Strategic collaborations between drug developers and CDMOs are becoming more prevalent, enabling shared risk and accelerated innovation.

The rising need for scalable solutions across the drug lifecycle, combined with advancements in process optimization and automation, creates significant opportunities for providers to differentiate through technical depth and regulatory expertise. Growing emphasis on speed-to-market, particularly for niche and orphan drugs, is further strengthening the role of specialized CDMOs that can deliver agile and compliant manufacturing. The competitive environment favors players who invest in technology integration, expand service portfolios, and build strong, long-term partnerships to address evolving therapeutic and manufacturing demands.

Small Molecule CDMO Market Report Highlights

By product, the active pharmaceutical ingredient segment dominated the market in 2024 driven by the increasing outsourcing of complex synthesis processes to specialized CDMOs.

Based on drug type, the innovators segment held the largest revenue share in 2024 due to the high level of outsourced manufacturing for novel small molecule therapies.

North America dominated the small molecule CDMO market in 2024 due to a strong presence of advanced pharmaceutical manufacturing infrastructure, well-established regulatory frameworks, and high demand for outsourcing from large-scale drug developers.

The market in Asia Pacific is expected to register the highest CAGR from 2025 to 2034 due to expanding pharmaceutical manufacturing capacity, increasing investments in advanced production facilities, and rising demand for cost-effective outsourcing solutions.

A few global key players in the small molecule CDMO market include Aurigene Pharmaceutical Services Ltd.; Bellen Chemistry; Cambrex Corporation; Catalent, Inc.; CordenPharma International; Eurofins Scientific; Lonza; Recipharm AB; Siegfried Holding AG; and Thermo Fisher Scientific Inc.

Polaris Market Research has segmented the market report on the basis of product, drug type, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Active Pharmaceutical Ingredients (API)

Finished Drug Products

By Drug Type Outlook (Revenue, USD Billion, 2020-2034)

Innovators

Generics

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiovascular Disease

Central Nervous System (CNS) Conditions

Autoimmune/Inflammation

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Small Molecule CDMO Market Insights

  • 4.1. Small Molecule CDMO Market - Market Snapshot
  • 4.2. Small Molecule CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Expansion of Generic Drug Production
      • 4.2.1.2. Rising R&D Activities in Emerging Therapeutic Areas
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory requirements and quality compliance standards increase operational complexity
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Small Molecule CDMO Market Trends
  • 4.6. Value Chain Analysis

5. Global Small Molecule CDMO Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Active Pharmaceutical Ingredients (API)
    • 5.3.1. Global Small Molecule CDMO Market, by Active Pharmaceutical Ingredients (API), by Region, 2020-2034 (USD Billion)
  • 5.4. Finished Drug Products
    • 5.4.1. Global Small Molecule CDMO Market, by Finished Drug Products, by Region, 2020-2034 (USD Billion)

6. Global Small Molecule CDMO Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • 6.3. Innovators
    • 6.3.1. Global Small Molecule CDMO Market, by Innovators, by Region, 2020-2034 (USD Billion)
  • 6.4. Generics
    • 6.4.1. Global Small Molecule CDMO Market, by Generics, by Region, 2020-2034 (USD Billion)
  • 6.5. Manual
    • 6.5.1. Global Small Molecule CDMO Market, by Manual, by Region, 2020-2034 (USD Billion)

7. Global Small Molecule CDMO Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Small Molecule CDMO Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Cardiovascular Disease
    • 7.4.1. Global Small Molecule CDMO Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Billion)
  • 7.5. Central Nervous System (CNS) Conditions
    • 7.5.1. Global Small Molecule CDMO Market, by Central Nervous System (CNS) Conditions, by Region, 2020-2034 (USD Billion)
  • 7.6. Autoimmune/Inflammation
    • 7.6.1. Global Small Molecule CDMO Market, by Autoimmune/Inflammation, by Region, 2020-2034 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Small Molecule CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Small Molecule CDMO Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Small Molecule CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Small Molecule CDMO Market - North America
    • 8.3.1. North America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.3.3. North America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.3.4. Small Molecule CDMO Market - U.S.
      • 8.3.4.1. U.S.: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.3.5. Small Molecule CDMO Market - Canada
      • 8.3.5.1. Canada: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.4. Small Molecule CDMO Market - Europe
    • 8.4.1. Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.4. Small Molecule CDMO Market - UK
      • 8.4.4.1. UK: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.5. Small Molecule CDMO Market - France
      • 8.4.5.1. France: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.6. Small Molecule CDMO Market - Germany
      • 8.4.6.1. Germany: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.7. Small Molecule CDMO Market - Italy
      • 8.4.7.1. Italy: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.8. Small Molecule CDMO Market - Spain
      • 8.4.8.1. Spain: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.9. Small Molecule CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.10. Small Molecule CDMO Market - Russia
      • 8.4.10.1. Russia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.4.11. Small Molecule CDMO Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.5. Small Molecule CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.4. Small Molecule CDMO Market - China
      • 8.5.4.1. China: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.5. Small Molecule CDMO Market - India
      • 8.5.5.1. India: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.6. Small Molecule CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.7. Small Molecule CDMO Market - Japan
      • 8.5.7.1. Japan: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.8. Small Molecule CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.9. Small Molecule CDMO Market - South Korea
      • 8.5.9.1. South Korea: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.10. Small Molecule CDMO Market - Australia
      • 8.5.10.1. Australia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.5.11. Small Molecule CDMO Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.6. Small Molecule CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.4. Small Molecule CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.5. Small Molecule CDMO Market - UAE
      • 8.6.5.1. UAE: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.6. Small Molecule CDMO Market - Israel
      • 8.6.6.1. Israel: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.7. Small Molecule CDMO Market - South Africa
      • 8.6.7.1. South Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.6.8. Small Molecule CDMO Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • 8.7. Small Molecule CDMO Market - Latin America
    • 8.7.1. Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.4. Small Molecule CDMO Market - Mexico
      • 8.7.4.1. Mexico: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.5. Small Molecule CDMO Market - Brazil
      • 8.7.5.1. Brazil: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.6. Small Molecule CDMO Market - Argentina
      • 8.7.6.1. Argentina: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
    • 8.7.7. Small Molecule CDMO Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Aurigene Pharmaceutical Services Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bellen Chemistry
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cambrex Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Catalent, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CordenPharma International
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Eurofins Scientific
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lonza
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Recipharm AB
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Siegfried Holding AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 3 Global Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 6 North America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 7 U.S.: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 9 U.S.: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Canada: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 12 Canada: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 15 Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 16 UK: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 18 UK: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 19 France: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 21 France: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Germany: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 24 Germany: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Italy: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 27 Italy: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Spain: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 30 Spain: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Russia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 36 Russia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 43 China: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 45 China: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 46 India: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 48 India: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Japan: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 54 Japan: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 58 South Korea: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 60 South Korea: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Australia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 63 Australia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 73 UAE: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 75 UAE: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Israel: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 78 Israel: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 79 South Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 81 South Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 87 Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Mexico: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 90 Mexico: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Brazil: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 93 Brazil: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 94 Argentina: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 96 Argentina: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Small Molecule CDMO Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Small Molecule CDMO Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Small Molecule CDMO Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Small Molecule CDMO Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Small Molecule CDMO Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Small Molecule CDMO Market, by Drug Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Small Molecule CDMO Market, by Application, 2024 & 2034 (USD Billion)